Latest Safety News

Page 40 of 146
Actinogen Medical has secured an initial $5.5 million R&D tax incentive rebate from the Australian Tax Office, with an additional $1.9 million pending, bolstering funding for its Alzheimer’s and depression drug trials.
Ada Torres
Ada Torres
15 Oct 2025
TerraCom Limited has extended the life of its Blair Athol Mine to 2033, supported by a robust 2025 JORC Code Resource and Reserve update. This reinforces the mine’s status as a low-cost, long-life asset underpinning stable cash flow and growth potential.
Maxwell Dee
Maxwell Dee
15 Oct 2025
29Metals maintains steady copper output at Golden Grove despite seismic disruptions to zinc production, while progressing key growth projects and regulatory steps toward Capricorn Copper’s restart.
Maxwell Dee
Maxwell Dee
15 Oct 2025
29Metals reports a steady copper output but significant zinc production decline due to seismic disruptions at Golden Grove, alongside rising operational costs and ongoing progress at Capricorn Copper.
Maxwell Dee
Maxwell Dee
15 Oct 2025
Argenica Therapeutics reports encouraging functional improvements in stroke patients treated with ARG-007, setting the stage for a targeted Phase 2b trial focused on patient-centered outcomes.
Ada Torres
Ada Torres
15 Oct 2025
Telix Pharmaceuticals reports a robust 53% revenue jump in Q3 2025 and raises its full-year guidance, underpinned by key reimbursement wins and expanding clinical programs.
Ada Torres
Ada Torres
14 Oct 2025
GenusPlus Group has secured an additional $75 million in contracts from Western Power, boosting its Clean Energy Link – North project involvement and launching a new underground power pilot program.
Maxwell Dee
Maxwell Dee
14 Oct 2025
Altech Batteries has raised $6 million through a share placement to accelerate development and commercialisation of its innovative battery technologies, including the CERENERGY solid-state battery and Silumina Anodes.
Victor Sage
Victor Sage
14 Oct 2025
Tryptamine Therapeutics has enrolled the first patient in its pioneering clinical trial testing TRP-8803, an IV-infused psilocin formulation, for Binge Eating Disorder. The study aims to evaluate safety and efficacy, potentially reshaping treatment options for millions.
Ada Torres
Ada Torres
14 Oct 2025
Ansell Limited has revealed unauthorized access to certain company data through vulnerabilities in licensed third-party software, with no disruption to operations. While most accessed data was non-sensitive, some confidential and personal information was involved.
Victor Sage
Victor Sage
14 Oct 2025
Paladin Energy reports a record uranium production quarter at its Langer Heinrich Mine alongside a robust engineering review of its Patterson Lake South Project, supported by a successful A$300 million equity raise.
Maxwell Dee
Maxwell Dee
14 Oct 2025
Paladin Energy reported a record uranium production quarter at its Langer Heinrich Mine alongside a successful A$300 million equity raise, positioning the company for accelerated development of its Patterson Lake South project.
Maxwell Dee
Maxwell Dee
14 Oct 2025